Insulin Therapy Center

The choice of human vs analogue insulin is especially important for people with Type 1 diabetes who live where healthcare resources are limited. Analogue insulins are often preferred because their action can be more predictable and flexible. However, human insulin is generally less expensive and may be easier for health …

For millions of people who use injectable diabetes medications, treatment can mean living with needles every day. What if a small skin patch could eventually deliver insulin or other therapies with far less discomfort? Researchers studying microneedle patches for diabetes hope to make that possibility practical. These experimental patches use …

Artificial intelligence is entering diabetes care in a surprisingly quiet way. Rather than appearing as a chatbot or separate decision-support tool, increasingly sophisticated algorithms are being built into automated insulin delivery systems. Adaptive insulin pump hardware can work with continuous glucose monitor (CGM) data, recent insulin delivery, and changing glucose …

For more than a century, insulin has saved millions of lives. Yet despite remarkable advances in diabetes technology, one major challenge remains: preventing hypoglycemia while maintaining excellent glucose control. That is why researchers are developing glucose-responsive insulin, often called “smart” insulin. Instead of delivering a fixed amount of insulin regardless …

For many people living with diabetes, gaining access to an automated insulin delivery (AID) system can be life-changing. These technologies help improve glycemic outcomes, reduce hypoglycemia risk, and ease the daily burden of diabetes management. Yet despite their proven benefits, many patients continue to face lengthy delays before gaining access. …

For many people living with diabetes, insulin is more than a medication—it is a lifeline. Yet despite its critical role, some patients stop taking insulin without informing their healthcare provider. The reasons vary widely and may include medication costs, treatment fatigue, fear of side effects, weight gain concerns, or misunderstandings …

Many healthcare providers focus heavily on daytime glucose control, yet some of the most dangerous hypoglycemic episodes occur while patients are asleep. Despite major advances in insulin therapy and glucose monitoring, nocturnal hypoglycemia remains a significant clinical concern for people living with diabetes. Because symptoms often go unnoticed during sleep, …

Patients treated with corticosteroids for asthma, COPD exacerbations, rheumatologic disease, inflammatory bowel disease, or cancer-related complications often develop significant elevations in blood glucose. In many cases, these patients have no prior history of diabetes. Yet within days of therapy initiation, blood glucose levels can rise dramatically, creating a challenging clinical …

For years, diabetes care has relied on one key rule: insulin should be given before meals whenever possible. Yet many people living with diabetes still struggle with timing. Busy schedules, unpredictable eating habits, and delayed dosing often lead to postprandial glucose spikes. Now, with the rise of ultra-rapid insulin AID …

Automated insulin delivery for people with type 2 diabetes is entering a new phase. What once seemed reserved for highly specialized endocrinology clinics is now moving steadily into primary care offices across the country. Following the updated 2026 American Diabetes Association Standards of Care and recent FDA clearances, more adults …